These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8736811)

  • 21. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA; Johnson O; Ericsson M; Tollin C
    Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexities of plasma apolipoprotein C-III metabolism.
    Sacks Editorial Board FM; Zheng C; Cohn Editorial Board JS
    J Lipid Res; 2011 Jun; 52(6):1067-1070. PubMed ID: 21421846
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.
    Desai NK; Ooi EM; Mitchell PD; Furtado J; Sacks FM
    Atherosclerosis; 2015 Aug; 241(2):326-33. PubMed ID: 26071654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.
    Syvänne M; Kahri J; Virtanen KS; Taskinen MR
    Circulation; 1995 Aug; 92(3):364-70. PubMed ID: 7634450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of serum lipoproteins in insulin-dependent (type I) and noninsulin-dependent (type II) diabetes mellitus.
    Weisweiler P; Merk W; Schwandt P
    Monogr Atheroscler; 1985; 13():104-10. PubMed ID: 4088272
    [No Abstract]   [Full Text] [Related]  

  • 27. [Apolipoproteins A and B in cerebrovascular diseases].
    Bruck J; Fischer M; Sluga E; Tschabitscher H
    Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lipoproteins of diabetic rats fed a high cholesterol diet.
    Arbeeny CM; Edelstein D; Freedman SR; Eder HA
    Diabetes; 1980 Oct; 29(10):774-7. PubMed ID: 7002659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.
    Durrington PN; Hunt L; Ishola M; Kane J; Stephens WP
    Br Heart J; 1986 Sep; 56(3):206-12. PubMed ID: 3092846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lipids and lipoproteins in patients treated with antiepileptic drugs.
    Verrotti A; Basciani F; Domizio S; Sabatino G; Morgese G; Chiarelli F
    Pediatr Neurol; 1998 Nov; 19(5):364-7. PubMed ID: 9880141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
    Laakso M; Lehto S; Penttilä I; Pyörälä K
    Circulation; 1993 Oct; 88(4 Pt 1):1421-30. PubMed ID: 8403288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.
    Kesäniemi YA; Beltz WF; Grundy SM
    J Clin Invest; 1985 Aug; 76(2):586-95. PubMed ID: 3861622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes.
    Mancini M; Pauciullo P; Cortese C; Rubba P; Riccardi G; Rivellese A
    Horm Metab Res Suppl; 1988; 19():13-5. PubMed ID: 3235056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of diabetes on the metabolism of triacylglycerol-rich lipoproteins.
    Arbeeny CM; Eder HA
    Biochem Soc Trans; 1989 Feb; 17(1):51-3. PubMed ID: 2714517
    [No Abstract]   [Full Text] [Related]  

  • 37. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
    Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
    Diabetologia; 1997 Apr; 40(4):454-62. PubMed ID: 9112023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus.
    Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
    Diabetologia; 2000 Jan; 43(1):27-35. PubMed ID: 10663213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin effectively reduced all triglyceride-rich liporoteins (VLDL and LDL) in type 2 diabetes using VAP analysis.
    Cardiovasc J S Afr; 2006; 17(4):216. PubMed ID: 17001431
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians.
    Howard BV
    Diabetes Care; 1993 Jan; 16(1):284-91. PubMed ID: 8422793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.